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Thyroid hormone and estradiol modulate biological processes by bind-
ing to nuclear receptor proteins that, through interactions with specific
response elements in the regulatory regions of genes, modulate gene
transcription. Both the estrogen receptor (ER) and thyroid hormone
receptor (TR) are members of the nuclear receptor superfamily
(Evans, 1988; Zhangand Lazar, 2000). These receptors have a
modular protein structure with high homology in the central DNA bind-
ing domain (Yen, 2001). The DNA-binding domain is the most con-
served region of the nuclear receptor superfamily responsible for target-
ing the receptor to highly specific DNA sequences comprising a
response element. It is known that ERs bind target response elements
with two consensus AGGTCA motifs in a palindromic array with a 3-
bp spacer (Trussand Beato, 1993). However, it has been demon-
strated that the same AGGTCA motifs but in other orientations serve as
targets for TRs (Yenand Chin, 1994). Published studies also indi-
cate that there are two major TR subtypes, TRa- and TRb- encoded, on
separate genes (Lazar, 1993). With alternative splicing, three func-
tional isoforms, TRa1, TRb1, and TRb2, have been identified. The ER
exists in two isoforms, a and b, which are products of different genes
showing promoter site specificity (Kuiper et al. 1996). 
It is known that thyroid hormones have major effects on the
female reproductive system (Gardner et al. 1978). They are critical
for growth, development and differentiation. However, there is insuffi-
cient evidence on interactions of these hormones with sex steroids in the
cells of reproductive tissues. In order to gain more information about
the relationship between thyroid and estrogen hormone actions, we
studied receptor binding parameters for both kinds of analyzed hor-
mones, as well as the competition in binding of these hormones to
nuclear receptors in the rat uterus.
Adult female rats of the Wistar strain (200-220 g b.w.) were used 
Fig. 1. Saturation curves and Scatchard plots of specific 
3HE and 
125IT3 binding in uterine nuclear extract. Samples were incubated for 2 h at 23
0C with the indicated con-
centration of 
3HE (0.125-10 nM) (A and B) or 125IT3 (0.12-7 nM) (C and D) in the absence or presence of a 1000-fold molar excess of unlabeled Des or T3. The results
represent the mean value of two individual experiments which performed with five females in each of them.
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for the experiments. Animals were ovariectomized seven days before
experiments. Nuclear extracts were prepared according to the methods
of Evans et al. (1983). The animals were killed by decapitation, and
the uteri were minced and homogenized in TEMG buffer (50 mM Tris-
HCl, 1 mM EDTA, 12 mM monothioglycerol, 30% glycerol, pH 7.5)
using an Ultra-Turrax homogenizer (3x30 sec). The homogenate was
filtered through four layers of gauze and centrifuged at 800xg for 15
min at 4
0C. The resultant pellet was washed by resuspension and cen-
trifugation twice in TMG buffer (20 mM Tris-HCl, 12 mM monothio-
glycerol, 10% glycerol, pH 7.5) containing 0.2% Triton X-100 and once
with TMG buffer alone. The washed nuclear pellet was then resuspend-
ed in TEMG buffer containing 0.5 M KCl and mixed at 15-min inter-
vals for 1 h. After centrifugation at 100.000xg for 1 h at 4
0 C, the
obtained supernatant (nuclear extract) was used in the binding studies.
Equilibrium binding studies were done by incubating aliquots of
nuclear extracts with increasing concentrations of [2,4,6,7-
3H(N)]-estra-
diol (SA 71 Ci/mmol, Perkin Elmer Life Sciences Inc., Boston, MA)
ranging from 0.125 to 10 nM, or 
125I-triiodothyronine (
125IT3) (SA 67
µCi/µg, Radioisotope Laboratory, Vinča Institute of Nuclear Sciences)
ranging from 0.12 to 7 nM in the absence (total binding) or in the pres-
ence (non-specific binding) of a 1000-fold excess of unlabeled hor-
mones, diethylstilbestrol (Des) or triiodothyronine (T3). After incuba-
tion, bound and free hormones were separated using the dextran-char-
coal absorption binding technique. Receptor binding parameters such as
the dissociation constant (Kd) and number of binding sites (N) for both
kinds of hormones were determined by Scatchard plot analyses
(Scatchard, 1949) using a computer program. Competition assays
were done by incubating aliquots of nuclear extracts with a single con-
centration of labeled hormones and varying the concentration of unla-
beled competitors (1x10
-9 - 1x10
-4 M) for 2 h at 23
0C. Protein concentra-
tion was measured by the method of Lowry et al. (1951).
The obtained results provide evidence for the presence of specific
receptors for both analyzed hormones. Binding properties of rat uterus
estrogen and thyroid hormone receptors are shown by representative
saturation curves and Scatchard plots in Fig. 1. The data indicate the
presence of a single class (linear Scatchard plot) of saturable and high-
affinity binding sites for both kinds of hormones. The Kd values
(Figs.1B and 1D) are in the range observed  for  
3HE and  
125IT3 binding
in other mammalian tissues (Evans et al. 1983). The results of our
study also indicate a limited capacity of those binding sites. The T 3
receptor concentration in rat uterus nuclei was much lower in compari-
son with the concentration of estrogen receptors in the same tissue. This
is in agreement with previously published data (Evans et al. 1983;
Mukku et al. 1983) that indicate a small number of T3 receptors in rat
uterus nuclei. Moreover, there are more high-affinity binding sites for
T3, which are responsible for the expected biological effects, in the liver
and kidney, than in the uterus (Evans et al. 1983). 
Since these studies indicate the presence of saturable and high-
affinity binding sites in uterine nuclear extracts, binding specificity of
these receptors was analyzed using the competitive equilibrium binding
method. The results of competition studies are shown in Fig. 2. 
Competition experiments revealed that 
3HE binding in the nuclear
extracts was markedly reduced by the presence of a 1000-fold molar
excess of unlabeled Des, but was not reduced by the presence of an
equivalent molar excess of unlabeled T3 (Fig. 2 A). Similar reduction of
125IT3 binding was observed in the presence of a 1000-fold molar excess
of unlabeled T3, and there was no competition by Des for 
125IT3 binding
(Fig. 2 B).
Taken together, the data presented herein confirm the presence of
specific, high-affinity binding sites for the analyzed hormones in rat
uterus, as well as no competition between these two hormones at the
receptor-binding level. The mechanisms responsible for the interaction
between estadiol and thyroid hormones are not yet known.
In vitro and in vivo data indicate that manipulations of estrogen
and thyroid hormone levels can alter each other's functions. One possi-
ble mechanism for interaction may be that thyroid and estrogen recep-
tors, having structural similarities, bind to an identical half-site,
AGGTCA, of their cognate hormone response elements and thereby can
compete with each other at this level (Vasudevan et al. 2002). It
follows that thyroid hormones and estrogen can interact through their
own receptors in several different modes, depending on TR and ER iso-
forms, hormone response elements, and the gene promoter and
cell type. 
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Fig. 2. Competition between 
3HE and 
125IT3 binding in uterine nuclear extract.
Samples were incubated for 2 h at 23
0C with 6 nM 
3HE (A) or 2 nM 
125IT3 (B) in
the absence (control) or presence of increasing concentrations of unlabeled homol-
ogous or heterologous competitors. The competitive binding curve is plotted as the
percentage of total bound radiolabeled hormones. Each point represents the mean
of two separate experiments performed with five animals in each of them.
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